Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 7.23901050 |
2 | * regulation of sequestering of triglyceride (GO:0010889) | 7.07673017 |
3 | fatty acid transmembrane transport (GO:1902001) | 6.69324091 |
4 | carnitine shuttle (GO:0006853) | 6.65533756 |
5 | valine metabolic process (GO:0006573) | 6.64430091 |
6 | biotin metabolic process (GO:0006768) | 6.43359536 |
7 | brown fat cell differentiation (GO:0050873) | 6.10780088 |
8 | fatty acid beta-oxidation (GO:0006635) | 5.84844119 |
9 | carnitine transmembrane transport (GO:1902603) | 5.47626810 |
10 | white fat cell differentiation (GO:0050872) | 5.46237272 |
11 | tricarboxylic acid cycle (GO:0006099) | 5.45514555 |
12 | positive regulation of fatty acid oxidation (GO:0046321) | 5.29161150 |
13 | regulation of fatty acid oxidation (GO:0046320) | 5.22562682 |
14 | NADH metabolic process (GO:0006734) | 5.14781318 |
15 | regulation of cholesterol storage (GO:0010885) | 5.14729809 |
16 | * triglyceride catabolic process (GO:0019433) | 5.13862322 |
17 | carnitine transport (GO:0015879) | 5.13491104 |
18 | amino-acid betaine transport (GO:0015838) | 5.13491104 |
19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.09131727 |
20 | fatty acid oxidation (GO:0019395) | 5.07872849 |
21 | lipid oxidation (GO:0034440) | 4.98754631 |
22 | fatty acid catabolic process (GO:0009062) | 4.97549868 |
23 | branched-chain amino acid catabolic process (GO:0009083) | 4.95600928 |
24 | branched-chain amino acid metabolic process (GO:0009081) | 4.91741558 |
25 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.74376095 |
26 | tricarboxylic acid metabolic process (GO:0072350) | 4.64221448 |
27 | * acylglycerol catabolic process (GO:0046464) | 4.58385326 |
28 | * neutral lipid catabolic process (GO:0046461) | 4.58385326 |
29 | diacylglycerol metabolic process (GO:0046339) | 4.57903748 |
30 | acetyl-CoA metabolic process (GO:0006084) | 4.40609871 |
31 | triglyceride biosynthetic process (GO:0019432) | 4.33091457 |
32 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.30932716 |
33 | 2-oxoglutarate metabolic process (GO:0006103) | 4.29697550 |
34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18669409 |
35 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.17977999 |
36 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.17866730 |
37 | positive regulation of lipid storage (GO:0010884) | 4.17105119 |
38 | thioester biosynthetic process (GO:0035384) | 4.15399494 |
39 | acyl-CoA biosynthetic process (GO:0071616) | 4.15399494 |
40 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.14769396 |
41 | acylglycerol biosynthetic process (GO:0046463) | 4.14312785 |
42 | neutral lipid biosynthetic process (GO:0046460) | 4.14312785 |
43 | intracellular lipid transport (GO:0032365) | 4.02441326 |
44 | quaternary ammonium group transport (GO:0015697) | 3.98402041 |
45 | oxaloacetate metabolic process (GO:0006107) | 3.94865756 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.94192718 |
47 | monocarboxylic acid catabolic process (GO:0072329) | 3.93135945 |
48 | carnitine metabolic process (GO:0009437) | 3.92456812 |
49 | * lipid particle organization (GO:0034389) | 3.87694042 |
50 | succinate metabolic process (GO:0006105) | 3.86257940 |
51 | regulation of coenzyme metabolic process (GO:0051196) | 3.84175130 |
52 | regulation of cofactor metabolic process (GO:0051193) | 3.84175130 |
53 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.71731571 |
54 | lysine catabolic process (GO:0006554) | 3.70163642 |
55 | lysine metabolic process (GO:0006553) | 3.70163642 |
56 | pentose-phosphate shunt (GO:0006098) | 3.67904142 |
57 | fatty acid homeostasis (GO:0055089) | 3.64672213 |
58 | coenzyme A biosynthetic process (GO:0015937) | 3.62928346 |
59 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.60337914 |
60 | plasma lipoprotein particle clearance (GO:0034381) | 3.58517076 |
61 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.56518879 |
62 | positive regulation of cholesterol efflux (GO:0010875) | 3.52351098 |
63 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.51075721 |
64 | short-chain fatty acid metabolic process (GO:0046459) | 3.49184480 |
65 | NADPH regeneration (GO:0006740) | 3.48691574 |
66 | * triglyceride metabolic process (GO:0006641) | 3.44826472 |
67 | barbed-end actin filament capping (GO:0051016) | 3.44403632 |
68 | long-chain fatty acid transport (GO:0015909) | 3.39871155 |
69 | * lipid storage (GO:0019915) | 3.37958516 |
70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35937934 |
71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35937934 |
72 | negative regulation of protein autophosphorylation (GO:0031953) | 3.35470193 |
73 | mannose metabolic process (GO:0006013) | 3.28535636 |
74 | * acylglycerol metabolic process (GO:0006639) | 3.23691301 |
75 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.18079177 |
76 | cellular response to epinephrine stimulus (GO:0071872) | 3.17521835 |
77 | * neutral lipid metabolic process (GO:0006638) | 3.17130211 |
78 | complement activation, alternative pathway (GO:0006957) | 3.16242737 |
79 | amino-acid betaine metabolic process (GO:0006577) | 3.15418266 |
80 | regulation of fatty acid metabolic process (GO:0019217) | 3.14629034 |
81 | regulation of sulfur metabolic process (GO:0042762) | 3.12745118 |
82 | negative regulation of granulocyte differentiation (GO:0030853) | 3.11740998 |
83 | * glycerolipid catabolic process (GO:0046503) | 3.09239464 |
84 | cardiolipin metabolic process (GO:0032048) | 3.08411635 |
85 | sulfur amino acid catabolic process (GO:0000098) | 3.05853968 |
86 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.05384343 |
87 | thioester metabolic process (GO:0035383) | 3.01685108 |
88 | acyl-CoA metabolic process (GO:0006637) | 3.01685108 |
89 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.01682459 |
90 | ethanol oxidation (GO:0006069) | 3.01673738 |
91 | coenzyme A metabolic process (GO:0015936) | 3.01501922 |
92 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.98808093 |
93 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.98675217 |
94 | transcytosis (GO:0045056) | 2.97438290 |
95 | cellular response to lithium ion (GO:0071285) | 2.96292363 |
96 | * cellular lipid catabolic process (GO:0044242) | 2.96148662 |
97 | fatty acid transport (GO:0015908) | 2.93424387 |
98 | stress fiber assembly (GO:0043149) | 2.92844076 |
99 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.92768439 |
100 | acylglycerol homeostasis (GO:0055090) | 2.91715568 |
101 | triglyceride homeostasis (GO:0070328) | 2.91715568 |
102 | protein heterotrimerization (GO:0070208) | 2.89851109 |
103 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88252069 |
104 | cellular response to zinc ion (GO:0071294) | 2.87645327 |
105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86061579 |
106 | growth hormone receptor signaling pathway (GO:0060396) | 2.85801652 |
107 | * regulation of lipid storage (GO:0010883) | 2.83206391 |
108 | * positive regulation of lipid catabolic process (GO:0050996) | 2.83082076 |
109 | positive regulation of histone deacetylation (GO:0031065) | 2.82765678 |
110 | positive regulation of cholesterol transport (GO:0032376) | 2.82657968 |
111 | positive regulation of sterol transport (GO:0032373) | 2.82657968 |
112 | glucose catabolic process (GO:0006007) | 2.79190435 |
113 | negative regulation of phagocytosis (GO:0050765) | 2.77563824 |
114 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.76836427 |
115 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.76633036 |
116 | regulation of cholesterol metabolic process (GO:0090181) | 2.76513679 |
117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75006876 |
118 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.73781758 |
119 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.69182252 |
120 | polyol transport (GO:0015791) | 2.65441949 |
121 | angiogenesis involved in wound healing (GO:0060055) | 2.64549745 |
122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62918379 |
123 | negative regulation of cell killing (GO:0031342) | 2.62918379 |
124 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.59268041 |
125 | positive regulation of receptor recycling (GO:0001921) | 2.58830225 |
126 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.54580043 |
127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53195288 |
128 | negative regulation of fatty acid transport (GO:2000192) | 2.52119308 |
129 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50907521 |
130 | ethanol metabolic process (GO:0006067) | 2.48466086 |
131 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.47084950 |
132 | fibril organization (GO:0097435) | 2.45493598 |
133 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.45168035 |
134 | response to epinephrine (GO:0071871) | 2.44123741 |
135 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.43929548 |
136 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.41363729 |
137 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.41322932 |
138 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.40945424 |
139 | apoptotic cell clearance (GO:0043277) | 2.33664700 |
140 | response to laminar fluid shear stress (GO:0034616) | 2.31175538 |
141 | regulation of cholesterol efflux (GO:0010874) | 2.30158216 |
142 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29559300 |
143 | extracellular fibril organization (GO:0043206) | 2.29082448 |
144 | regulation of necrotic cell death (GO:0010939) | 2.27618869 |
145 | creatine metabolic process (GO:0006600) | 2.27598398 |
146 | detection of bacterium (GO:0016045) | 2.27389604 |
147 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.26984651 |
148 | detection of other organism (GO:0098543) | 2.26621637 |
149 | adherens junction assembly (GO:0034333) | 2.26336150 |
150 | focal adhesion assembly (GO:0048041) | 2.24753922 |
151 | cell-substrate adherens junction assembly (GO:0007045) | 2.24753922 |
152 | regulation of receptor binding (GO:1900120) | 2.24111132 |
153 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.23320011 |
154 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.23138623 |
155 | basement membrane organization (GO:0071711) | 2.22895300 |
156 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.21763947 |
157 | positive regulation of glucose import (GO:0046326) | 2.16063913 |
158 | regulation of cholesterol transport (GO:0032374) | 2.15880191 |
159 | regulation of sterol transport (GO:0032371) | 2.15880191 |
160 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.15228463 |
161 | cellular response to nutrient (GO:0031670) | 2.14573170 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.80890589 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.57672166 |
3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.73067050 |
4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57788417 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.42487387 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04430955 |
7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51942792 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45643671 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28554613 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.25117900 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08764865 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01865233 |
13 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 12.2219161 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93962871 |
15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.78383928 |
16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.78383928 |
17 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75168317 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 1.74018226 |
19 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71786382 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69953459 |
21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67324763 |
22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.65243599 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63946879 |
24 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.63283031 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60655710 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56640457 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55703664 |
28 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54529604 |
29 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54328176 |
30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54002882 |
31 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.50441435 |
32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50024358 |
33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48454527 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46347803 |
35 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44987565 |
36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44788484 |
37 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44417829 |
38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42840351 |
39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42145164 |
40 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.40697850 |
41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39968899 |
42 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37858742 |
43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35633526 |
44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35554552 |
45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35443980 |
46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34360982 |
47 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33989050 |
48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32147486 |
49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31790354 |
50 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.31718039 |
51 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31193924 |
52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.29942037 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28417941 |
54 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.26262850 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25927518 |
56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25718343 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25660943 |
58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23283412 |
59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22640173 |
60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22624626 |
61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22084610 |
62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21919923 |
63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19814461 |
64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17383293 |
65 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17220934 |
66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17097567 |
67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16891374 |
68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16565801 |
69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15913290 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13596350 |
71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13307319 |
72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12946782 |
73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12906087 |
74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12295247 |
75 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11989388 |
76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11484978 |
77 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11451145 |
78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11159190 |
79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09908831 |
80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09763029 |
81 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09196771 |
82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06123224 |
83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06091408 |
84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05833393 |
85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05609860 |
86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04541901 |
87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03834817 |
88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03668499 |
89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03217793 |
90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03206736 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03051593 |
92 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02816601 |
93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02782656 |
94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01900664 |
95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01550964 |
96 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01002671 |
97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99728791 |
98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98992733 |
99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98742248 |
100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97681293 |
101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96477956 |
102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95073301 |
103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94301130 |
104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94274797 |
105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94223107 |
106 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92784756 |
107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92283723 |
108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91536662 |
109 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91203729 |
110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90176984 |
111 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89838316 |
112 | * MAF_26560356_Chip-Seq_TH1_Human | 0.88740940 |
113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88430995 |
114 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87866487 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86967380 |
116 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.86562138 |
117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85775731 |
118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85255064 |
119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83386457 |
120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83201709 |
121 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.81857645 |
122 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80895640 |
123 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.80554583 |
124 | * P68_20966046_ChIP-Seq_HELA_Human | 0.80430022 |
125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79849061 |
126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78994108 |
127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78770439 |
128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78154059 |
129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77977634 |
130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77002624 |
131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76428782 |
132 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76250550 |
133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75986980 |
134 | SPI1_23127762_ChIP-Seq_K562_Human | 0.75888835 |
135 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75766008 |
136 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.75240369 |
137 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74301535 |
138 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74192352 |
139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73505243 |
140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73372107 |
141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.72493304 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 6.46281292 |
2 | MP0005666_abnormal_adipose_tissue | 4.66849921 |
3 | MP0004130_abnormal_muscle_cell | 4.64394538 |
4 | MP0004185_abnormal_adipocyte_glucose | 3.98877401 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 3.95494881 |
6 | MP0005375_adipose_tissue_phenotype | 3.30540455 |
7 | MP0003646_muscle_fatigue | 2.93565338 |
8 | MP0008438_abnormal_cutaneous_collagen | 2.83493095 |
9 | * MP0002971_abnormal_brown_adipose | 2.62842801 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.40340627 |
11 | * MP0010329_abnormal_lipoprotein_level | 2.31273572 |
12 | MP0000751_myopathy | 2.19524310 |
13 | MP0009115_abnormal_fat_cell | 2.19385089 |
14 | MP0000003_abnormal_adipose_tissue | 2.15645978 |
15 | MP0000013_abnormal_adipose_tissue | 2.12267275 |
16 | MP0003303_peritoneal_inflammation | 1.98656605 |
17 | MP0005275_abnormal_skin_tensile | 1.91341699 |
18 | * MP0002118_abnormal_lipid_homeostasis | 1.89169870 |
19 | * MP0005334_abnormal_fat_pad | 1.88311619 |
20 | MP0004084_abnormal_cardiac_muscle | 1.86934984 |
21 | MP0003724_increased_susceptibility_to | 1.84112378 |
22 | MP0005365_abnormal_bile_salt | 1.79961947 |
23 | MP0005330_cardiomyopathy | 1.75787589 |
24 | MP0003705_abnormal_hypodermis_morpholog | 1.74230211 |
25 | MP0006036_abnormal_mitochondrial_physio | 1.73055028 |
26 | * MP0002970_abnormal_white_adipose | 1.63876708 |
27 | MP0003828_pulmonary_edema | 1.61670741 |
28 | MP0002139_abnormal_hepatobiliary_system | 1.59807448 |
29 | MP0004036_abnormal_muscle_relaxation | 1.59735761 |
30 | MP0008775_abnormal_heart_ventricle | 1.59144928 |
31 | * MP0004087_abnormal_muscle_fiber | 1.58698305 |
32 | MP0000750_abnormal_muscle_regeneration | 1.57903127 |
33 | MP0004215_abnormal_myocardial_fiber | 1.56349189 |
34 | MP0005451_abnormal_body_composition | 1.54220906 |
35 | MP0000343_altered_response_to | 1.50606092 |
36 | MP0008260_abnormal_autophagy | 1.46952077 |
37 | MP0000749_muscle_degeneration | 1.46694946 |
38 | * MP0000609_abnormal_liver_physiology | 1.45932530 |
39 | * MP0001544_abnormal_cardiovascular_syste | 1.43163805 |
40 | * MP0005385_cardiovascular_system_phenoty | 1.43163805 |
41 | MP0005360_urolithiasis | 1.43003714 |
42 | MP0004858_abnormal_nervous_system | 1.42464926 |
43 | * MP0005535_abnormal_body_temperature | 1.41273944 |
44 | MP0003186_abnormal_redox_activity | 1.40625927 |
45 | MP0000858_altered_metastatic_potential | 1.40260689 |
46 | MP0002933_joint_inflammation | 1.39589930 |
47 | MP0001661_extended_life_span | 1.38688292 |
48 | MP0005076_abnormal_cell_differentiation | 1.30783621 |
49 | MP0002876_abnormal_thyroid_physiology | 1.29624434 |
50 | MP0009278_abnormal_bone_marrow | 1.29615225 |
51 | * MP0005620_abnormal_muscle_contractility | 1.26572728 |
52 | MP0005448_abnormal_energy_balance | 1.26220055 |
53 | MP0004510_myositis | 1.25904981 |
54 | MP0005332_abnormal_amino_acid | 1.24571619 |
55 | MP0005319_abnormal_enzyme/_coenzyme | 1.24393836 |
56 | MP0003959_abnormal_lean_body | 1.23299005 |
57 | MP0002419_abnormal_innate_immunity | 1.22851832 |
58 | * MP0002972_abnormal_cardiac_muscle | 1.22526430 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21074332 |
60 | MP0000759_abnormal_skeletal_muscle | 1.19768443 |
61 | * MP0002078_abnormal_glucose_homeostasis | 1.19609427 |
62 | MP0005503_abnormal_tendon_morphology | 1.19109012 |
63 | MP0009840_abnormal_foam_cell | 1.18271487 |
64 | MP0003172_abnormal_lysosome_physiology | 1.16347735 |
65 | MP0000767_abnormal_smooth_muscle | 1.15646509 |
66 | MP0003091_abnormal_cell_migration | 1.14599354 |
67 | MP0004272_abnormal_basement_membrane | 1.14594992 |
68 | * MP0010630_abnormal_cardiac_muscle | 1.14511972 |
69 | * MP0006138_congestive_heart_failure | 1.14434763 |
70 | MP0005025_abnormal_response_to | 1.13134068 |
71 | MP0003075_altered_response_to | 1.10948498 |
72 | MP0002998_abnormal_bone_remodeling | 1.09866463 |
73 | MP0003566_abnormal_cell_adhesion | 1.09326141 |
74 | MP0002106_abnormal_muscle_physiology | 1.08829516 |
75 | MP0004947_skin_inflammation | 1.08570418 |
76 | MP0009643_abnormal_urine_homeostasis | 1.07567400 |
77 | MP0003453_abnormal_keratinocyte_physiol | 1.07504318 |
78 | MP0005409_darkened_coat_color | 1.06710738 |
79 | MP0002166_altered_tumor_susceptibility | 1.05098906 |
80 | MP0001881_abnormal_mammary_gland | 1.04022024 |
81 | MP0001849_ear_inflammation | 1.01206338 |
82 | MP0002269_muscular_atrophy | 1.00234907 |
83 | MP0001879_abnormal_lymphatic_vessel | 0.98040972 |
84 | MP0001853_heart_inflammation | 0.97941645 |
85 | MP0008961_abnormal_basal_metabolism | 0.96543766 |
86 | MP0005058_abnormal_lysosome_morphology | 0.96508603 |
87 | MP0005000_abnormal_immune_tolerance | 0.95926205 |
88 | MP0002332_abnormal_exercise_endurance | 0.95851361 |
89 | * MP0005452_abnormal_adipose_tissue | 0.95479360 |
90 | MP0009785_altered_susceptibility_to | 0.95062754 |
91 | MP0002254_reproductive_system_inflammat | 0.93146311 |
92 | MP0005387_immune_system_phenotype | 0.92053679 |
93 | MP0001790_abnormal_immune_system | 0.92053679 |
94 | MP0001851_eye_inflammation | 0.89379054 |
95 | MP0002108_abnormal_muscle_morphology | 0.88938849 |
96 | MP0005085_abnormal_gallbladder_physiolo | 0.88178350 |
97 | MP0005390_skeleton_phenotype | 0.88026277 |
98 | MP0002909_abnormal_adrenal_gland | 0.87797184 |
99 | MP0010155_abnormal_intestine_physiology | 0.86977323 |
100 | MP0003868_abnormal_feces_composition | 0.86245104 |
101 | MP0003690_abnormal_glial_cell | 0.85133957 |
102 | MP0005369_muscle_phenotype | 0.82649334 |
103 | MP0005595_abnormal_vascular_smooth | 0.82329945 |
104 | MP0000747_muscle_weakness | 0.81609297 |
105 | MP0005464_abnormal_platelet_physiology | 0.81396259 |
106 | MP0002060_abnormal_skin_morphology | 0.81161700 |
107 | MP0001756_abnormal_urination | 0.80916723 |
108 | MP0005083_abnormal_biliary_tract | 0.80364211 |
109 | MP0004484_altered_response_of | 0.80143884 |
110 | MP0005023_abnormal_wound_healing | 0.80040585 |
111 | MP0009333_abnormal_splenocyte_physiolog | 0.77532898 |
112 | MP0003279_aneurysm | 0.77494161 |
113 | MP0003950_abnormal_plasma_membrane | 0.77105973 |
114 | MP0002796_impaired_skin_barrier | 0.76673241 |
115 | MP0005166_decreased_susceptibility_to | 0.76386043 |
116 | MP0003448_altered_tumor_morphology | 0.75313271 |
117 | MP0002132_abnormal_respiratory_system | 0.75088603 |
118 | MP0003011_delayed_dark_adaptation | 0.74777604 |
119 | MP0000230_abnormal_systemic_arterial | 0.74737174 |
120 | MP0002420_abnormal_adaptive_immunity | 0.74448228 |
121 | MP0001819_abnormal_immune_cell | 0.74031421 |
122 | MP0001835_abnormal_antigen_presentation | 0.73918464 |
123 | MP0003763_abnormal_thymus_physiology | 0.73553671 |
124 | * MP0003221_abnormal_cardiomyocyte_apopto | 0.70907566 |
125 | MP0009763_increased_sensitivity_to | 0.68798770 |
126 | MP0003300_gastrointestinal_ulcer | 0.68298765 |
127 | MP0010368_abnormal_lymphatic_system | 0.68106359 |
128 | MP0005167_abnormal_blood-brain_barrier | 0.66360852 |
129 | MP0002006_tumorigenesis | 0.64520401 |
130 | MP0003045_fibrosis | 0.63672515 |
131 | * MP0000249_abnormal_blood_vessel | 0.63553523 |
132 | MP0004147_increased_porphyrin_level | 0.63141347 |
133 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62734727 |
134 | MP0005164_abnormal_response_to | 0.62684327 |
135 | MP0000685_abnormal_immune_system | 0.62475853 |
136 | MP0001533_abnormal_skeleton_physiology | 0.62293598 |
137 | MP0000598_abnormal_liver_morphology | 0.61785142 |
138 | MP0001958_emphysema | 0.61617466 |
139 | MP0003252_abnormal_bile_duct | 0.60122818 |
140 | MP0005397_hematopoietic_system_phenotyp | 0.57416156 |
141 | MP0001545_abnormal_hematopoietic_system | 0.57416156 |
142 | * MP0003953_abnormal_hormone_level | 0.57336368 |
143 | MP0003436_decreased_susceptibility_to | 0.56069093 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myoglobinuria (HP:0002913) | 5.48269265 |
2 | Hyperglycinuria (HP:0003108) | 5.33514507 |
3 | Oligomenorrhea (HP:0000876) | 5.06670035 |
4 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.64953333 |
5 | Rhabdomyolysis (HP:0003201) | 4.54323428 |
6 | Hypoglycemic coma (HP:0001325) | 4.50999826 |
7 | Acanthosis nigricans (HP:0000956) | 4.36464752 |
8 | Abnormality of glycine metabolism (HP:0010895) | 4.31565602 |
9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31565602 |
10 | Dicarboxylic aciduria (HP:0003215) | 3.99008524 |
11 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.99008524 |
12 | Increased connective tissue (HP:0009025) | 3.88609519 |
13 | Protrusio acetabuli (HP:0003179) | 3.83632811 |
14 | Ketoacidosis (HP:0001993) | 3.83094881 |
15 | Exercise-induced myalgia (HP:0003738) | 3.80779465 |
16 | Muscle fiber splitting (HP:0003555) | 3.67635424 |
17 | Ketosis (HP:0001946) | 3.67055209 |
18 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.66153421 |
19 | * Hypertriglyceridemia (HP:0002155) | 3.61589700 |
20 | Hyperammonemia (HP:0001987) | 3.51786367 |
21 | Nausea (HP:0002018) | 3.29060257 |
22 | Lipoatrophy (HP:0100578) | 3.28243485 |
23 | Hepatic necrosis (HP:0002605) | 3.28000036 |
24 | Complement deficiency (HP:0004431) | 3.24556402 |
25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.22232832 |
26 | Ventricular tachycardia (HP:0004756) | 3.20135987 |
27 | Generalized aminoaciduria (HP:0002909) | 3.19690665 |
28 | Hyporeflexia of lower limbs (HP:0002600) | 3.19106019 |
29 | Abnormality of proline metabolism (HP:0010907) | 3.12518643 |
30 | Hydroxyprolinuria (HP:0003080) | 3.12518643 |
31 | Type 1 muscle fiber predominance (HP:0003803) | 3.09215201 |
32 | Sudden death (HP:0001699) | 3.07750443 |
33 | Right ventricular cardiomyopathy (HP:0011663) | 3.05909703 |
34 | Eczematoid dermatitis (HP:0000976) | 3.01676773 |
35 | Hypoalphalipoproteinemia (HP:0003233) | 3.01234873 |
36 | Obstructive sleep apnea (HP:0002870) | 3.01205642 |
37 | Vertebral compression fractures (HP:0002953) | 2.90694180 |
38 | Exercise-induced muscle cramps (HP:0003710) | 2.83138477 |
39 | Muscle stiffness (HP:0003552) | 2.82846542 |
40 | Axonal loss (HP:0003447) | 2.80609448 |
41 | Asymmetric septal hypertrophy (HP:0001670) | 2.79362771 |
42 | Bone cyst (HP:0012062) | 2.76584163 |
43 | Palpitations (HP:0001962) | 2.76403015 |
44 | Hyperglycinemia (HP:0002154) | 2.72355341 |
45 | Cervical subluxation (HP:0003308) | 2.71395055 |
46 | Increased variability in muscle fiber diameter (HP:0003557) | 2.71346129 |
47 | Distal lower limb amyotrophy (HP:0008944) | 2.69227629 |
48 | Distal lower limb muscle weakness (HP:0009053) | 2.68470300 |
49 | Insulin resistance (HP:0000855) | 2.68220410 |
50 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.64365325 |
51 | Colitis (HP:0002583) | 2.63459213 |
52 | Facial diplegia (HP:0001349) | 2.61909816 |
53 | Multiple enchondromatosis (HP:0005701) | 2.60469227 |
54 | * Increased muscle lipid content (HP:0009058) | 2.60121598 |
55 | Hyperlipoproteinemia (HP:0010980) | 2.57092774 |
56 | Xanthomatosis (HP:0000991) | 2.56651113 |
57 | Dysostosis multiplex (HP:0000943) | 2.55104233 |
58 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51768013 |
59 | Amyloidosis (HP:0011034) | 2.47271965 |
60 | Dilated cardiomyopathy (HP:0001644) | 2.47236800 |
61 | Calf muscle hypertrophy (HP:0008981) | 2.45816157 |
62 | Stridor (HP:0010307) | 2.44786074 |
63 | Hypercortisolism (HP:0001578) | 2.43502500 |
64 | Hemorrhage of the eye (HP:0011885) | 2.36662343 |
65 | Broad metatarsal (HP:0001783) | 2.36594863 |
66 | Abnormality of complement system (HP:0005339) | 2.35591648 |
67 | Aortic aneurysm (HP:0004942) | 2.32310482 |
68 | Premature rupture of membranes (HP:0001788) | 2.26653032 |
69 | Epidermoid cyst (HP:0200040) | 2.26593421 |
70 | Bulbar palsy (HP:0001283) | 2.26338260 |
71 | Myocardial infarction (HP:0001658) | 2.26222532 |
72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.26004052 |
73 | Prolonged bleeding time (HP:0003010) | 2.24907079 |
74 | Conjunctival hamartoma (HP:0100780) | 2.24502397 |
75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.23679935 |
76 | Myositis (HP:0100614) | 2.23161229 |
77 | Growth hormone excess (HP:0000845) | 2.22017999 |
78 | Ankle contracture (HP:0006466) | 2.21632709 |
79 | Aneurysm (HP:0002617) | 2.21555070 |
80 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21105229 |
81 | Cellulitis (HP:0100658) | 2.19769148 |
82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19708635 |
83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19708635 |
84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19708635 |
85 | Lymphangioma (HP:0100764) | 2.18235108 |
86 | Increased IgE level (HP:0003212) | 2.17873971 |
87 | Hepatocellular necrosis (HP:0001404) | 2.17431112 |
88 | Emphysema (HP:0002097) | 2.17335955 |
89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16654609 |
90 | Pancreatitis (HP:0001733) | 2.16574088 |
91 | Thin bony cortex (HP:0002753) | 2.16523734 |
92 | Lethargy (HP:0001254) | 2.16054579 |
93 | Gingivitis (HP:0000230) | 2.15349922 |
94 | Proximal tubulopathy (HP:0000114) | 2.14946556 |
95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14228665 |
96 | Mucopolysacchariduria (HP:0008155) | 2.14228665 |
97 | Gastrointestinal inflammation (HP:0004386) | 2.11355409 |
98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11099717 |
99 | Dilatation of the ascending aorta (HP:0005111) | 2.09903745 |
100 | Atrioventricular block (HP:0001678) | 2.08197948 |
101 | Atrial fibrillation (HP:0005110) | 2.07992045 |
102 | Vomiting (HP:0002013) | 2.07565790 |
103 | Metabolic acidosis (HP:0001942) | 2.07360029 |
104 | Toxemia of pregnancy (HP:0100603) | 2.07354510 |
105 | Joint stiffness (HP:0001387) | 2.07194248 |
106 | Cerebral edema (HP:0002181) | 2.06999705 |
107 | Abnormality of alanine metabolism (HP:0010916) | 2.06705711 |
108 | Hyperalaninemia (HP:0003348) | 2.06705711 |
109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.06705711 |
110 | Myotonia (HP:0002486) | 2.06316350 |
111 | Broad face (HP:0000283) | 2.06149227 |
112 | Skin nodule (HP:0200036) | 2.05798980 |
113 | Bundle branch block (HP:0011710) | 2.05070857 |
114 | Spinal rigidity (HP:0003306) | 2.04032576 |
115 | Prenatal maternal abnormality (HP:0002686) | 2.03340149 |
116 | Abnormal cartilage morphology (HP:0002763) | 2.03232687 |
117 | Pigmentary retinal degeneration (HP:0001146) | 2.02865327 |
118 | Spontaneous hematomas (HP:0007420) | 2.00879991 |
119 | Abnormality of macrophages (HP:0004311) | 2.00808110 |
120 | Neoplasm of head and neck (HP:0012288) | 2.00780860 |
121 | Esophageal neoplasm (HP:0100751) | 2.00780860 |
122 | * Difficulty running (HP:0009046) | 2.00778234 |
123 | Inflammation of the large intestine (HP:0002037) | 2.00313065 |
124 | Abnormality of purine metabolism (HP:0004352) | 2.00294206 |
125 | Gastrointestinal dysmotility (HP:0002579) | 2.00215600 |
126 | Polygenic inheritance (HP:0010982) | 2.00057743 |
127 | Cerebral aneurysm (HP:0004944) | 1.99985160 |
128 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99305034 |
129 | Shallow orbits (HP:0000586) | 1.97146631 |
130 | Tetraparesis (HP:0002273) | 1.97044336 |
131 | Abnormal hemoglobin (HP:0011902) | 1.96215206 |
132 | Methylmalonic aciduria (HP:0012120) | 1.94800033 |
133 | Hyperglycemia (HP:0003074) | 1.94395707 |
134 | Subaortic stenosis (HP:0001682) | 1.93546309 |
135 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.93546309 |
136 | Polycythemia (HP:0001901) | 1.93186116 |
137 | Lactic acidosis (HP:0003128) | 1.92272017 |
138 | Systemic lupus erythematosus (HP:0002725) | 1.91632723 |
139 | Long foot (HP:0001833) | 1.91601513 |
140 | Hepatosplenomegaly (HP:0001433) | 1.91299227 |
141 | Orchitis (HP:0100796) | 1.90715433 |
142 | Ileus (HP:0002595) | 1.89136001 |
143 | Renal cortical cysts (HP:0000803) | 1.88526550 |
144 | Autoimmune thrombocytopenia (HP:0001973) | 1.88228988 |
145 | Large hands (HP:0001176) | 1.88207855 |
146 | Hypercholesterolemia (HP:0003124) | 1.86641240 |
147 | Recurrent abscess formation (HP:0002722) | 1.86195188 |
148 | Myopathic facies (HP:0002058) | 1.85953651 |
149 | Mitral regurgitation (HP:0001653) | 1.85349026 |
150 | Malnutrition (HP:0004395) | 1.81957114 |
151 | Gastrointestinal stroma tumor (HP:0100723) | 1.80248776 |
152 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79915192 |
153 | Biconcave vertebral bodies (HP:0004586) | 1.79217024 |
154 | Blue sclerae (HP:0000592) | 1.79095702 |
155 | Ectopia lentis (HP:0001083) | 1.76585164 |
156 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74025659 |
157 | Nuclear cataract (HP:0100018) | 1.72889466 |
158 | Wormian bones (HP:0002645) | 1.72855775 |
159 | Vascular tortuosity (HP:0004948) | 1.71899389 |
160 | Gastrointestinal infarctions (HP:0005244) | 1.69900113 |
161 | Fragile skin (HP:0001030) | 1.69143011 |
162 | Foot dorsiflexor weakness (HP:0009027) | 1.68800457 |
163 | Difficulty climbing stairs (HP:0003551) | 1.68119989 |
164 | Peritonitis (HP:0002586) | 1.68008320 |
165 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65669154 |
166 | Joint hemorrhage (HP:0005261) | 1.65629777 |
167 | Polar cataract (HP:0010696) | 1.65623678 |
168 | Slender build (HP:0001533) | 1.65379428 |
169 | Abnormality of the nasal mucosa (HP:0000433) | 1.64948648 |
170 | Back pain (HP:0003418) | 1.63650396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.28227854 |
2 | BCKDK | 4.80073091 |
3 | CAMK1D | 3.98451030 |
4 | PDK3 | 3.81504429 |
5 | PDK4 | 3.81504429 |
6 | SIK1 | 3.15193742 |
7 | ERN1 | 3.00474452 |
8 | CAMK1G | 2.80317507 |
9 | TTN | 2.77994045 |
10 | PRPF4B | 2.67513417 |
11 | LMTK2 | 2.56622037 |
12 | PDK2 | 2.38102823 |
13 | PKN2 | 2.21988400 |
14 | RIPK4 | 2.05054526 |
15 | RIPK1 | 2.03789484 |
16 | TIE1 | 1.89168144 |
17 | TESK1 | 1.87647292 |
18 | TGFBR2 | 1.82434047 |
19 | MYLK | 1.70257782 |
20 | PHKG1 | 1.64220529 |
21 | PHKG2 | 1.64220529 |
22 | SMG1 | 1.63969599 |
23 | PRKAA2 | 1.62845351 |
24 | MST1R | 1.56564685 |
25 | OBSCN | 1.51050699 |
26 | TNK2 | 1.50648581 |
27 | MAP3K13 | 1.44201589 |
28 | FGFR4 | 1.40890400 |
29 | TAOK1 | 1.39310549 |
30 | MARK2 | 1.29023772 |
31 | PRKD2 | 1.28336266 |
32 | MAP2K3 | 1.25754676 |
33 | PIK3CA | 1.20565240 |
34 | TAOK2 | 1.20446288 |
35 | EPHA2 | 1.19189804 |
36 | CDC42BPA | 1.16355607 |
37 | MAP3K1 | 1.16259424 |
38 | EPHB1 | 1.14011809 |
39 | FLT3 | 1.12979949 |
40 | DDR2 | 1.09956545 |
41 | KDR | 1.05058951 |
42 | NEK9 | 1.04359534 |
43 | JAK1 | 1.03958621 |
44 | GRK6 | 1.01791609 |
45 | PDGFRA | 1.01305265 |
46 | INSRR | 1.00065809 |
47 | BLK | 0.99391000 |
48 | CDK9 | 0.99164877 |
49 | FGFR3 | 0.97544729 |
50 | FES | 0.95221304 |
51 | PINK1 | 0.94591412 |
52 | DMPK | 0.94227374 |
53 | IRAK4 | 0.94209019 |
54 | PRKAA1 | 0.91709930 |
55 | TBK1 | 0.90428664 |
56 | IRAK3 | 0.89205014 |
57 | HIPK2 | 0.88911450 |
58 | CDK6 | 0.86341187 |
59 | MAPKAPK3 | 0.84368554 |
60 | ILK | 0.82667991 |
61 | MAPK7 | 0.81421354 |
62 | SIK3 | 0.80295365 |
63 | TYK2 | 0.80232740 |
64 | JAK2 | 0.79045269 |
65 | JAK3 | 0.78796112 |
66 | PAK4 | 0.78203760 |
67 | EEF2K | 0.77724435 |
68 | KSR2 | 0.77716002 |
69 | PDPK1 | 0.77480897 |
70 | MAP4K1 | 0.77044029 |
71 | EPHB2 | 0.76919073 |
72 | PTK6 | 0.75830169 |
73 | RPS6KA2 | 0.73715447 |
74 | ARAF | 0.71099524 |
75 | MAPK11 | 0.70488799 |
76 | BTK | 0.70286528 |
77 | MAP2K1 | 0.69580533 |
78 | PRKD1 | 0.67995972 |
79 | LRRK2 | 0.67154373 |
80 | MAP3K3 | 0.67050205 |
81 | HCK | 0.65768467 |
82 | MAP3K7 | 0.64999897 |
83 | PDK1 | 0.64898121 |
84 | CDK12 | 0.64357716 |
85 | PTK2 | 0.62701315 |
86 | MAPK12 | 0.60941554 |
87 | DYRK1B | 0.60371811 |
88 | TESK2 | 0.59121254 |
89 | MOS | 0.58382811 |
90 | ZAP70 | 0.58265561 |
91 | KIT | 0.58189573 |
92 | STK38 | 0.57596768 |
93 | MAP2K2 | 0.57530382 |
94 | MAP3K14 | 0.56984323 |
95 | PTK2B | 0.54834581 |
96 | PRKG2 | 0.54297319 |
97 | PRKD3 | 0.53163070 |
98 | PIK3CG | 0.51604537 |
99 | MET | 0.51053824 |
100 | EPHA3 | 0.49642641 |
101 | CSK | 0.49595132 |
102 | PRKACG | 0.48964707 |
103 | NME2 | 0.48773134 |
104 | IRAK2 | 0.48724709 |
105 | MTOR | 0.48526742 |
106 | CDK4 | 0.46576678 |
107 | MAP2K6 | 0.45496579 |
108 | PRKCH | 0.43949906 |
109 | ICK | 0.43510028 |
110 | NEK1 | 0.43487137 |
111 | FGFR2 | 0.42930914 |
112 | CSF1R | 0.42089193 |
113 | GSK3A | 0.41531942 |
114 | RET | 0.40365070 |
115 | MAPK15 | 0.40138497 |
116 | MAP3K6 | 0.39540674 |
117 | PDGFRB | 0.37147244 |
118 | CAMK1 | 0.37040597 |
119 | TRPM7 | 0.36230817 |
120 | DAPK3 | 0.34715117 |
121 | IGF1R | 0.34640033 |
122 | ABL2 | 0.34281397 |
123 | FRK | 0.34070534 |
124 | MAP3K10 | 0.34020968 |
125 | BMX | 0.33882287 |
126 | IRAK1 | 0.32155482 |
127 | IKBKE | 0.30680894 |
128 | FER | 0.29095634 |
129 | LATS1 | 0.28714825 |
130 | MAPK4 | 0.27737063 |
131 | WNK4 | 0.26703493 |
132 | PAK2 | 0.26561673 |
133 | TGFBR1 | 0.25541855 |
134 | MAP3K11 | 0.24488352 |
135 | NLK | 0.24480456 |
136 | RPS6KA6 | 0.22954901 |
137 | TEC | 0.21996347 |
138 | RPS6KL1 | 0.20283764 |
139 | RPS6KC1 | 0.20283764 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.92641752 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.69523713 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.82291129 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.79366032 |
5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.68993584 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.65608374 |
7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.62692680 |
8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.39460094 |
9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.52640843 |
10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.43721567 |
11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43130543 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42120450 |
13 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.16518688 |
14 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93320501 |
15 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.83427739 |
16 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.72320099 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61296533 |
18 | Peroxisome_Homo sapiens_hsa04146 | 1.60272067 |
19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59741709 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59457632 |
21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49486577 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48927620 |
23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.48622212 |
24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47820849 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45916044 |
26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.42707227 |
27 | Malaria_Homo sapiens_hsa05144 | 1.39717229 |
28 | Insulin resistance_Homo sapiens_hsa04931 | 1.29454229 |
29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23794301 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23282249 |
31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16377297 |
32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11301416 |
33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11278380 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09083796 |
35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07030408 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06421610 |
37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05227488 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04110136 |
39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04109551 |
40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02687479 |
41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02624567 |
42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02305402 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00936954 |
44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99270235 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96464698 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95200573 |
47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94599399 |
48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90010430 |
49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89164224 |
50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88675201 |
51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86717800 |
52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83521695 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.81978726 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81812230 |
55 | Pertussis_Homo sapiens_hsa05133 | 0.81766727 |
56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79824546 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 0.77102414 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76807062 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75363124 |
60 | Tuberculosis_Homo sapiens_hsa05152 | 0.74788048 |
61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73894547 |
62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73210660 |
63 | Platelet activation_Homo sapiens_hsa04611 | 0.72145762 |
64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68833425 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67786762 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67590170 |
67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67031092 |
68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66357558 |
69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64304625 |
70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64121384 |
71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63811782 |
72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63085294 |
73 | Prion diseases_Homo sapiens_hsa05020 | 0.62464336 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61898921 |
75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60589102 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.58822760 |
77 | Influenza A_Homo sapiens_hsa05164 | 0.57601180 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57316565 |
79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56325269 |
80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55609579 |
81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55463769 |
82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55265653 |
83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55191351 |
84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54578293 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54255573 |
86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53170422 |
87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52997676 |
88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52931992 |
89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52916439 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51770187 |
91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51552826 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51491470 |
93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51278948 |
94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51196129 |
95 | Allograft rejection_Homo sapiens_hsa05330 | 0.51112504 |
96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51046604 |
97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50780285 |
98 | Bladder cancer_Homo sapiens_hsa05219 | 0.49341650 |
99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48748262 |
100 | Endocytosis_Homo sapiens_hsa04144 | 0.48156634 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47337292 |
102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46495349 |
103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46350899 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46309502 |
105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46306291 |
106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46291373 |
107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46211039 |
108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45344548 |
109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45062504 |
110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44573482 |
111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44356439 |
112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44247801 |
113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43663685 |
114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43306645 |
115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43061875 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41256668 |
117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41019915 |
118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40964934 |
119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39095448 |
120 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38206342 |
121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38139581 |
122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37147001 |
123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36885395 |
124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32259934 |
125 | Bile secretion_Homo sapiens_hsa04976 | 0.32025075 |
126 | Focal adhesion_Homo sapiens_hsa04510 | 0.31110620 |
127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29218436 |
128 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.28279645 |
129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28071733 |
130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27946793 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25518062 |
132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22656671 |
133 | Lysosome_Homo sapiens_hsa04142 | 0.22037561 |
134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21920637 |
135 | Renin secretion_Homo sapiens_hsa04924 | 0.21616300 |
136 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21602138 |
137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19765903 |
138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19081954 |
139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18797721 |
140 | Amoebiasis_Homo sapiens_hsa05146 | 0.17722579 |
141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.15355596 |
142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15295433 |
143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.13871564 |
144 | Legionellosis_Homo sapiens_hsa05134 | 0.13655026 |
145 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.12707117 |
146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12688673 |
147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12438821 |
148 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.11594144 |
149 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11117509 |
150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11017769 |
151 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.10599049 |